Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors.
Evert S M van Aken, Ajeet Kumar Gandhi, Sean M O'Cathail, Gerben Borst, Jorge Barriuso, Emmanouil Fokas, Luis Castelo-Branco, Anne Hansen Ree, Evandro de Azambuja, Stephanie Kroeze, Ilaria Colombo, Antonin Levy, Carmen Criscitiello, Maximilian Niyazi, Nadia Harbeck
Published: 202510.1016/j.radonc.2025.111330
Abstract
BACKGROUND: While combining radiotherapy (RT) with targeted agents or immunotherapy may improve outcomes, it may also increase toxicity. High-quality toxicity data and multidisciplinary, evidence-based guidelines on the combination of these treatment…
Preview only. Read the full abstract at the source